EXCEPTIONAL LICENSING AND INVESTMENT OPPORTUNITIES
HB Biotechnologies Corporation holds patents in 40 countries including Japan, all 38 member countries of the European Patent Organisation, and Canada. Pending USA.
The Company maintains significant manufacturing partnerships with industry powerhouses to produce the commercial products and provide the scale, infrastructure, and supply chain necessary for the sustained growth of a global brand.
With patented superabsorbent technology, our next generation of supplements provides a premium, standalone brand that no one else can offer.
Only HB Biotech can provide visual proof of product effectiveness for consumers in this way - a distinct competitive advantage.
Compelling licensing and investment potential for the manufacturing and marketing of these innovative superabsorbent supplement products in the HB pipeline. Reach us at contact@hb-biotechnologies.com to discuss further.